RCT Abstract - Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomized, double-blind, placebo-controlled, phase 3 trial
Jean-Marc Naccache, Stephane Jouneau, Morgane Didier, Raphaël Borie, Marine Cachanado, Arnaud Bourdin, Martine Reynaud-Gaubert, Philippe Bonniaud, Dominique Israel-Biet, Gregoire Prevot, Sandrine Hirschi, Francois Lebargy, Sylvain Marchand-Adam, Nathalie Bautin, Julie Traclet, Emmanuel Gomez, Sylvie Leroy, Frederic Gagnadoux, Frederic Rivière, Emmanuel Bergot, Anne Gondouin, Elodie Blanchard, Antoine Parrot, Francois-Xavier Blanc, Alexandre Chabrol, Stephane Dominique, Aude Gibelin, Abdellatif Tazi, Laurence Berard, Pierre-Yves Brillet, Marie-Pierre Debray, Alexandra Rousseau, Malorie Kerjouan, Olivia Freynet, Marie-Christine Dombret, Anne-Sophie Gamez, Ana Nieves, Guillaume Beltramo, Jean Pastré, Aurélie Le Borgne-Krams, Tristan Dégot, Claire Launois, Laurent Plantier, Lidwine Wémeau-Stervinou, Jacques Cadranel, Cécile Chenivesse, Dominique Valeyre, Bruno Crestani, Vincent Cottin, Tabassome Simon, Hilario Nunes
European Respiratory Journal Sep 2021, 58 (suppl 65) RCT2903; DOI: 10.1183/13993003.congress-2021.RCT2903
